Creating new Therapeutics With Advanced Transdermal Drug Delivery

Gary Cleary, Ph.D.

Dr. Cleary has held R&D and management positions at the FDA, ALZA, Key Pharmaceuticals and Genentech and was a founder of Cygnus. Dr. Cleary holds over 25 issued U.S. patents related to transdermal, mucosal and polymer science. Dr. Cleary earned a PharmD from University of California, San Francisco, an MBA in health sciences from the University of Miami and a PhD in pharmaceutics from Rutgers University.